What is Pilloxa?
Pilloxa Solutions operates a sophisticated platform designed to enhance patient engagement and empowerment throughout their treatment journeys. By offering a branded application, Pilloxa facilitates a more connected patient experience, underpinned by standardized pricing and consistent feature updates. This approach aims to eliminate hidden costs and provide clear value to patients. Furthermore, the platform delivers real-time insights, enabling healthcare providers to improve treatment outcomes and foster continuous learning within the medical community. As a subsidiary of iZafe Group AB, Pilloxa leverages expertise in medical technology and healthcare solutions to drive innovation in patient care.
How much funding has Pilloxa raised?
Pilloxa has raised a total of $1.3M across 1 funding round:
Other Financing Round
$1.3M
Other Financing Round (2019): $1.3M with participation from Bonnier Ventures
Key Investors in Pilloxa
Bonnier Ventures
Bonnier Ventures is an investment firm that typically backs companies with strong growth potential. Their involvement suggests a belief in Pilloxa's market strategy and scalability within the healthcare technology sector.
What's next for Pilloxa?
The recent major strategic investment signals Pilloxa's transition into a significant growth phase. With substantial enterprise-level backing, the company is poised to expand its market reach, further develop its platform's capabilities, and potentially explore new therapeutic areas or geographical markets. This capital infusion will likely be directed towards enhancing technological infrastructure, scaling sales and marketing efforts, and forging strategic partnerships within the healthcare ecosystem. Pilloxa's focus on patient empowerment and data-driven insights positions it for continued success in the evolving landscape of digital health.
See full Pilloxa company page
